SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
|
SCHEDULE 13G
|
|
Under the Securities Exchange Act of 1934
|
|
(Amendment No. 2)*
|
|
TapImmune Inc.
|
|
(Name of Issuer)
|
|
Common Stock, $0.001 par value
|
|
(Title of Class of Securities)
|
|
876033309
|
|
(CUSIP Number)
|
|
December 31, 2016
|
|
(Date of event which requires filing of this statement)
|
|
Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
|
|
¨
|
Rule 13d-1(b)
|
x
|
Rule 13d-1(c)
|
¨
|
Rule 13d-1(d)
|
(Page 1 of 11 Pages)
|
1
|
NAMES OF REPORTING PERSONS
Iroquois Capital Management L.L.C.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) o
(b) o
|
|
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER
358,025 shares of Common Stock
312,501 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
208,334 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
358,025 shares of Common Stock
312,501 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
208,334 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
358,025 shares of Common Stock
312,501 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
208,334 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
o
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6% (See Item 4)*
|
||
12
|
TYPE OF REPORTING PERSON
OO
|
1
|
NAMES OF REPORTING PERSONS
Richard Abbe
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) o
(b) o
|
|
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER
358,025 shares of Common Stock
312,501 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
208,334 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
358,025 shares of Common Stock
312,501 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
208,334 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
358,025 shares of Common Stock
312,501 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
208,334 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
o
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6% (See Item 4)*
|
||
12
|
TYPE OF REPORTING PERSON
IN
|
1
|
NAMES OF REPORTING PERSONS
Kimberly Page
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) o
(b) o
|
|
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
234,000 shares of Common Stock
187,500 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
125,067 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
|
6
|
SHARED VOTING POWER
358,025 shares of Common Stock
312,501 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
208,334 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
7
|
SOLE DISPOSITIVE POWER
234,000 shares of Common Stock
187,500 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
125,067 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
8
|
SHARED DISPOSITIVE POWER
358,025 shares of Common Stock
312,501 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
208,334 shares of Common Stock issuable upon exercise of Series C and F Warrants (See Item 4)*
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
592,025 shares of Common Stock
500,001 shares of Common Stock issuable upon exercise of Series A, D and E Warrants (See Item 4)*
333,401 shares of Common Stock issuable upon exercise of Series C Warrants (See Item 4)*
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
o
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.9% (See Item 4)*
|
||
12
|
TYPE OF REPORTING PERSON
IN
|
Item 2(a).
|
Name of Person Filing:
|
Iroquois Capital Management, LLC, Delaware limited liability company (“Iroquois”); Richard Abbe; and Kimberly Page. Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.
|
Item 2(b).
|
Address of Principal Business Office or, if None, Residence:
|
The address of the principal office of each of the Reporting Persons is 205 East 42nd Street, 20th Floor, New York, New York 10017.
|
Item 2(c).
|
Citizenship:
Iroquois Capital is incorporated in Delaware. Mr. Abbe and Ms. Page are citizens of the United States of America.
|
Item 4.
|
Ownership.
|
Item 10.
|
CERTIFICATION.
|
Each of the Reporting Persons hereby makes the following certification:
|
By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
IROQUOIS CAPITAL MANAGEMENT L.L.C.
By: /s/ Richard Abbe
Richard Abbe, Authorized Signatory
/s/ Richard Abbe
Richard Abbe
/s/ Kimberly Page Kimberly Page
|
Exhibit 1
|
Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
|
IROQUOIS CAPITAL MANAGEMENT L.L.C.
By: /s/ Richard Abbe
Richard Abbe, Authorized Signatory
/s/ Richard Abbe
Richard Abbe
/s/ Kimberly Page
Kimberly Page
|